Breaking Down the Barriers for the Development of new Therapeutics and Diagnostics

Learn what is being done that will greatly affect advancing clinical research and clinical care. This session will discuss how the FDA and the Wound Care Collaborative Community (WCCC) is working together on several projects which are intended to disrupt the long-standing barriers of bringing innovation to the bedside of our patients. The program is appropriate for clinicians, researchers, and product development professionals as well as C-suite executives and investors.